These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 20837346)
1. First clinical experience of Ankaferd BloodStopper as a hemostatic agent in partial nephrectomy. Huri E; Akgül T; Ayyildiz A; Bağcioğlu M; Germiyanoğlu C Kaohsiung J Med Sci; 2010 Sep; 26(9):493-5. PubMed ID: 20837346 [TBL] [Abstract][Full Text] [Related]
2. Hemostatic role of a folkloric medicinal plant extract in a rat partial nephrectomy model: controlled experimental trial. Huri E; Akgül T; Ayyildiz A; Ustün H; Germiyanoğlu C J Urol; 2009 May; 181(5):2349-54. PubMed ID: 19303089 [TBL] [Abstract][Full Text] [Related]
3. Hemostatic efficacy of Ankaferd Blood Stopper in a swine bleeding model. Bilgili H; Kosar A; Kurt M; Onal IK; Goker H; Captug O; Shorbagi A; Turgut M; Kekilli M; Kurt OK; Kirazli S; Aksu S; Haznedaroglu IC Med Princ Pract; 2009; 18(3):165-9. PubMed ID: 19349716 [TBL] [Abstract][Full Text] [Related]
4. New coagulant agent (ankaferd blood stopper) for open hemorrhages in hemophilia with inhibitor. Öner AF; Doğan M; Kaya A; Sal E; Bektaş MS; Yesilmen O; Ayhan H; Acikgoz M Clin Appl Thromb Hemost; 2010 Dec; 16(6):705-7. PubMed ID: 19528064 [TBL] [Abstract][Full Text] [Related]
5. Protective value of a folkloric medicinal plant extract against mortality and hemorrhage in a life-threatening renal trauma model. Tokgöz H; Karakaya K; Hanci V; Abduşoğlu M; Erol B; Türksoy O; Akduman B; Mungan NA Urology; 2010 Jun; 75(6):1515.e9-14. PubMed ID: 20223504 [TBL] [Abstract][Full Text] [Related]
6. The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model. Kosar A; Cipil HS; Kaya A; Uz B; Haznedaroglu IC; Goker H; Ozdemir O; Ercetin S; Kirazli S; Firat HC Blood Coagul Fibrinolysis; 2009 Apr; 20(3):185-90. PubMed ID: 19657315 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of hemostatic effects of Ankaferd as an alternative medicine. Beyazit Y; Kurt M; Kekilli M; Goker H; Haznedaroglu IC Altern Med Rev; 2010 Dec; 15(4):329-36. PubMed ID: 21194248 [TBL] [Abstract][Full Text] [Related]
9. Ankaferd Blood Stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract. Kurt M; Kacar S; Onal IK; Akdogan M; Haznedaroglu IC Endoscopy; 2008 Sep; 40 Suppl 2():E262. PubMed ID: 19090459 [No Abstract] [Full Text] [Related]
10. Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability. Kurt M; Oztas E; Kuran S; Onal IK; Kekilli M; Haznedaroglu IC Am J Emerg Med; 2009 Jun; 27(5):631.e1-2. PubMed ID: 19497484 [TBL] [Abstract][Full Text] [Related]
11. A new practical alternative for the control of sternal bleeding during cardiac surgery: Ankaferd Blood Stopper. Ergenoglu MU; Yerebakan H; Kucukaksu DS Heart Surg Forum; 2010 Dec; 13(6):E379-80. PubMed ID: 21169147 [TBL] [Abstract][Full Text] [Related]
12. Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper. Haznedaroglu BZ; Haznedaroglu IC; Walker SL; Bilgili H; Goker H; Kosar A; Aktas A; Captug O; Kurt M; Ozdemir O; Kirazli S; Firat HC Clin Appl Thromb Hemost; 2010 Aug; 16(4):446-53. PubMed ID: 19833624 [TBL] [Abstract][Full Text] [Related]
13. Use of Ankaferd Blood Stopper as a hemostatic agent: a clinical experience. Baykul T; Alanoglu EG; Kocer G J Contemp Dent Pract; 2010 Jan; 11(1):E088-94. PubMed ID: 20098971 [TBL] [Abstract][Full Text] [Related]
14. Postoperative adhesions after application of topical hemostatic agents: outcomes in a rat partial nephrectomy model. Tokgöz H; Bektaş S; Hancı V; Erol B; Akduman B; Karakaya K; Hakimolu S; Aydın Mungan N Urology; 2011 Oct; 78(4):970.e9-14. PubMed ID: 21820703 [TBL] [Abstract][Full Text] [Related]
15. Effective management of hemoptysis via endobronchial application of Ankaferd hemostat. Uzun O; Erkan L; Haznedaroglu IC Arch Bronconeumol; 2014 Sep; 50(9):407-9. PubMed ID: 24491888 [TBL] [Abstract][Full Text] [Related]
16. Topical Ankaferd hemostat application for the management of oral cavity bleedings in children with hemorrhagic diathesis. Leblebisatan G; Bay A; Karakus SC; Kekilli M; Haznedaroglu IC Blood Coagul Fibrinolysis; 2012 Sep; 23(6):494-7. PubMed ID: 22576286 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of microporous polysaccharide hemospheres as a novel hemostatic agent in open partial nephrectomy: favorable experimental results in the porcine model. Murat FJ; Ereth MH; Dong Y; Piedra MP; Gettman MT J Urol; 2004 Sep; 172(3):1119-22. PubMed ID: 15311053 [TBL] [Abstract][Full Text] [Related]
18. In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin. Cipil HS; Kosar A; Kaya A; Uz B; Haznedaroglu IC; Goker H; Ozdemir O; Koroglu M; Kirazli S; Firat HC Clin Appl Thromb Hemost; 2009; 15(3):270-6. PubMed ID: 19117967 [TBL] [Abstract][Full Text] [Related]
19. The effect of ankaferd to stop bleeding in experimental partial nephrectomy. Yalcinkaya FR; Kerem M; Guven EO; Gokce A; Davarci M Bratisl Lek Listy; 2011; 112(12):676-8. PubMed ID: 22372331 [TBL] [Abstract][Full Text] [Related]